| Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants L Santarelli, M Saxe, C Gross, A Surget, F Battaglia, S Dulawa, ... Science 301 (5634), 805, 2003 | 5254 | 2003 |
| Neuroinflammation and depression: A review R Troubat, P Barone, S Leman, T Desmidt, A Cressant, B Atanasova, ... European Journal of Neuroscience 53 (1), 151-171, 2021 | 656 | 2021 |
| Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal A Surget, M Saxe, S Leman, Y Ibarguen-Vargas, S Chalon, G Griebel, ... Biological psychiatry 64 (4), 293-301, 2008 | 607 | 2008 |
| Antidepressants recruit new neurons to improve stress response regulation A Surget, A Tanti, ED Leonardo, A Laugeray, Q Rainer, C Touma, ... Molecular psychiatry 16 (12), 1177-1188, 2011 | 519 | 2011 |
| Animal models of major depression: drawbacks and challenges B Planchez, A Surget, C Belzung Journal of Neural Transmission 126, 1383-1408, 2019 | 381 | 2019 |
| A molecular signature of depression in the amygdala E Sibille, Y Wang, J Joeyen-Waldorf, C Gaiteri, A Surget, S Oh, C Belzung, ... American journal of psychiatry 166 (9), 1011-1024, 2009 | 223 | 2009 |
| Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal A Surget, Y Wang, S Leman, Y Ibarguen-Vargas, N Edgar, G Griebel, ... Neuropsychopharmacology 34 (6), 1363-1380, 2009 | 211 | 2009 |
| Differential environmental regulation of neurogenesis along the septo-temporal axis of the hippocampus A Tanti, Q Rainer, F Minier, A Surget, C Belzung Neuropharmacology 63 (3), 374-384, 2012 | 181 | 2012 |
| Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey I Yalcin, C Belzung, A Surget Behavioural brain research 193 (1), 140-143, 2008 | 165 | 2008 |
| Multifaceted strain-specific effects in a mouse model of depression and of antidepressant reversal Y Ibarguen-Vargas, A Surget, C Touma, R Palme, C Belzung Psychoneuroendocrinology 33 (10), 1357-1368, 2008 | 129 | 2008 |
| Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress Y Ibarguen-Vargas, A Surget, P Vourc'h, S Leman, CR Andres, ... Behavioural brain research 202 (2), 245-251, 2009 | 128 | 2009 |
| Peripheral and cerebral metabolic abnormalities of the tryptophan–kynurenine pathway in a murine model of major depression A Laugeray, JM Launay, J Callebert, A Surget, C Belzung, PR Barone Behavioural brain research 210 (1), 84-91, 2010 | 118 | 2010 |
| Involvement of vasopressin in affective disorders A Surget, C Belzung European journal of pharmacology 583 (2-3), 340-349, 2008 | 110 | 2008 |
| Region‐dependent and stage‐specific effects of stress, environmental enrichment, and antidepressant treatment on hippocampal neurogenesis A Tanti, WP Westphal, V Girault, B Brizard, S Devers, AM Leguisquet, ... Hippocampus 23 (9), 797-811, 2013 | 109 | 2013 |
| Adult hippocampal neurogenesis: Is it the alpha and omega of antidepressant action? H Eliwa, C Belzung, A Surget Biochemical pharmacology 141, 86-99, 2017 | 76 | 2017 |
| Adult hippocampal neurogenesis and antidepressants effects B Planchez, A Surget, C Belzung Current opinion in pharmacology 50, 88-95, 2020 | 74* | 2020 |
| Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: Focus on individual differences A Laugeray, JM Launay, J Callebert, A Surget, C Belzung, PR Barone Pharmacology Biochemistry and Behavior 98 (1), 161-168, 2011 | 70 | 2011 |
| Increasing adult hippocampal neurogenesis in mice after exposure to unpredictable chronic mild stress may counteract some of the effects of stress L Culig, A Surget, M Bourdey, W Khemissi, AM Le Guisquet, E Vogel, ... Neuropharmacology 126, 179-189, 2017 | 65 | 2017 |
| Adult hippocampal neurogenesis shapes adaptation and improves stress response: a mechanistic and integrative perspective A Surget, C Belzung Molecular Psychiatry 27 (1), 403-421, 2022 | 62 | 2022 |
| Neuropeptides in psychiatric diseases: an overview with a particular focus on depression and anxiety disorders C Belzung, I Yalcin, G Griebel, A Surget, S Leman CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2006 | 58 | 2006 |
Catherine BelzungProfesseur de Neurosciences Université de ToursVerified email at univ-tours.fr
